C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2004
12/28/2004	US6835712 Compounds
12/28/2004	US6835569 Amino polyol oxidase amine polynucleotides and related polypeptides and methods of use
12/28/2004	US6835568 Regulated nucleic acid expression system
12/28/2004	US6835567 PNS cell lines and methods of use therefor
12/28/2004	US6835564 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same
12/28/2004	US6835561 Composition of reverse transcriptases and mutants thereof
12/28/2004	US6835557 DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
12/28/2004	US6835555 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
12/28/2004	US6835550 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
12/28/2004	US6835548 Isoforms of mouse serotonin 5-HT2c receptor
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835544 Methods of screening for compounds that bind to activin receptor
12/28/2004	US6835542 For providing kinetic and thermodynamic components in an assay for detecting target sequences
12/28/2004	US6835540 Biosynthetic pathway transcription factors
12/28/2004	US6835539 Nucleic sequences coding for an AT2 interacting proteins interacting with the AT2 receptor and their applications
12/28/2004	US6835538 Method of genetic modification of a wild type viral sequence
12/28/2004	US6835384 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains
12/28/2004	US6835370 Diagnosis and treatment of malignant neoplasms
12/28/2004	CA2315147C Methods and apparatus for performing sequence homology detection
12/28/2004	CA2072874C Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides
12/26/2004	CA2458893A1 Treatment of chronic human viral hepatitis
12/23/2004	WO2004111644A1 Substrate for biomolecule microarray, biomolecule microarray, device and method for interaction acceleration, and interaction detecting method
12/23/2004	WO2004111620A1 Bioassay substrate and bioassay device and method
12/23/2004	WO2004111608A2 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
12/23/2004	WO2004111271A2 Means and method for the detection of target nucleotide sequences using ligation assays with improved oligonucleotide probe pairs
12/23/2004	WO2004111267A2 Methods for preparation of a library of submegabase resolution tiling pools and uses thereof
12/23/2004	WO2004111252A1 Efficient production of transgenic animals
12/23/2004	WO2004111251A2 Modified fiber proteins for efficient receptor binding
12/23/2004	WO2004111250A1 Recombinant adeno-associated virus vector for treatment of alzheimer disease
12/23/2004	WO2004111249A2 Protein constructs containing caspase recognition sites
12/23/2004	WO2004111248A2 Improved aav vector for gene therapy
12/23/2004	WO2004111247A1 Circular expression construct for gene therapeutic applications
12/23/2004	WO2004111246A1 Protein production system
12/23/2004	WO2004111245A2 Gdc-2 genes conferring herbicide resistance
12/23/2004	WO2004111244A2 Methods for the production of insulin in plants
12/23/2004	WO2004111243A1 Stabilisation of mrna transcripts
12/23/2004	WO2004111242A1 FACTOR VII OR VIIa GLA DOMAIN VARIANTS
12/23/2004	WO2004111241A1 Penicillin acylase
12/23/2004	WO2004111240A2 Sequence for the bacillomycin d synthesis in bacillus amyloliquefaciens fzb42
12/23/2004	WO2004111239A1 Human embryonic kidney (hek) 293 subclone cell strain
12/23/2004	WO2004111238A1 Transcription regulatory sequence
12/23/2004	WO2004111237A1 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET-DERIVED ENDOTHELIAL CELL GROWTH FACTOR (ECGF1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/23/2004	WO2004111230A1 Strain belonging to the genus streptomyces and being capable of producing nemadictin and process for producing nemadictin using the strain
12/23/2004	WO2004111229A1 Methylomic analysis-cytosine cellular signatures
12/23/2004	WO2004111228A1 Methods for producing secreted polypeptides
12/23/2004	WO2004111227A2 Screening process for hydantoin racemases
12/23/2004	WO2004111225A1 Novel modified corin molecules having substitute activation sequences and uses thereof
12/23/2004	WO2004111223A1 Proteases
12/23/2004	WO2004111222A1 Proteases
12/23/2004	WO2004111221A1 Proteases
12/23/2004	WO2004111220A1 Proteases
12/23/2004	WO2004111219A1 Improved proteases and methods for producing them
12/23/2004	WO2004111218A2 Method for producing glucoamylases and their uses
12/23/2004	WO2004111217A2 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products
12/23/2004	WO2004111216A2 Phospholipase variants
12/23/2004	WO2004111214A1 Feedback-resistant mevalonate kinases
12/23/2004	WO2004111195A2 Methods and use of zona-free therapeutic cloning
12/23/2004	WO2004111194A2 Method to increase protein production in culture
12/23/2004	WO2004111191A2 Methods and compositions for controlling efficacy of rna silencing
12/23/2004	WO2004111190A2 IN VIVO HIGH THROUGHPUT SELECTION OF EFFECTIVE RNAi PROBES
12/23/2004	WO2004111189A2 Transgenic animal having an amyloid precursor protein with a modified beta secretase cleavage site
12/23/2004	WO2004111187A2 Methods for identification of coronaviruses
12/23/2004	WO2004111183A2 Plant trichome-specific promoter and leucoplast signal sequence
12/23/2004	WO2004111182A2 Methods for cloning nucleic acids in a desired orientation
12/23/2004	WO2004111089A2 Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
12/23/2004	WO2004111074A2 In vivo production of a clostridial neurotoxin light chain peptide
12/23/2004	WO2004111072A2 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same
12/23/2004	WO2004110964A2 Encoded molecules by translation (emt)
12/23/2004	WO2004110698A2 Methods and systems for processing microfeature workpieces with flow agitators and/or multiple electrodes
12/23/2004	WO2004110485A1 Materials and methods for improved vaccination
12/23/2004	WO2004110481A2 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
12/23/2004	WO2004110471A1 Preventive or remedy for disease associated with apoptosis
12/23/2004	WO2004110362A2 Immunotherapeutics for biodefense
12/23/2004	WO2004110345A2 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
12/23/2004	WO2004099403A8 A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar.
12/23/2004	WO2004090140A3 Methods and means for increasing the tolerance of plants to stress conditions
12/23/2004	WO2004089066A9 Manipulation of organic acid biosynthesis and secretion
12/23/2004	WO2004087929A3 Plants having improved growth characteristics and a method for making the same
12/23/2004	WO2004081217A3 Method for increasing resistance against stress factors in plants
12/23/2004	WO2004076623A3 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth
12/23/2004	WO2004076620A3 Human antibodies specific for interleukin 15 (il-15)
12/23/2004	WO2004074440A3 Preparation of organisms with faster growth and/or higher yield
12/23/2004	WO2004074439A9 An expression cassette and vector for transient or stable expression of exogenous molecules
12/23/2004	WO2004074310A8 Mycobacterial diagnostics
12/23/2004	WO2004072269A3 Bex4 nucleic acids, polypeptides, and method of using
12/23/2004	WO2004072263A3 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
12/23/2004	WO2004072229A3 Chemical treatment of biological samples for nucleic acid extraction and kits therefor
12/23/2004	WO2004067706A3 Production of multimeric proteins
12/23/2004	WO2004065543A3 Devices and method for recovery of a target molecule from a sample
12/23/2004	WO2004063356A3 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
12/23/2004	WO2004053132A8 A salt tolerant l-myo-inositol 1 phosphate synthase and the process of obtaining the same
12/23/2004	WO2004042002A3 Compounds for modulating rna interference
12/23/2004	WO2004041213A3 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein
12/23/2004	WO2004033633A3 Compatible host/vector systems for expression of dna
12/23/2004	WO2004020575A3 Methods and systems for detection and isolation of a nucleotide sequence
12/23/2004	WO2004005479A3 A high resolution typing system for pathogenic borrelia
12/23/2004	WO2003106692A3 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/23/2004	WO2003106491A3 Cell penetrating peptides
12/23/2004	WO2003104427A3 Methods and compositions for detecting cancers
12/23/2004	WO2003101497A8 Knockout mice and their use

1 ... 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 ... 4023